Bryan J. Winn

Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome.

The ocular surface microbiome of patients taking unilateral preserved glaucoma drops is characterized by a highly diverse array of gram-negative bacteria that is significantly different from the predominantly gram-positive microbes detected on healthy control eyes.

Glaucoma and the Human Microbiome.

Bacterial lipopolysaccharides (LPS) activate toll-like receptors (TLR) and mediate the human immune response.